SURGERY PARTNERS, INC. ANNOUNCES PRICING OF ADD-ON

SURGERY PARTNERS, INC. ANNOUNCES PRICING OF

ADD-ON NOTES OFFERING

BRENTWOOD, Tenn., December 11, 2025 (GLOBE NEWSWIRE) - Surgery Partners,

Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery

Center Holdings, Inc. (the "Issuer"), priced $425.0 million aggregate principal amount of its 7.250% senior unsecured notes

due 2032 (the "Notes") in a previously announced private offering exempt from the registration requirements of the Securities

Act of 1933, as amended (the "Securities Act"). The offering is expected to close on December 16, 2025, subject to certain

customary closing conditions. The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic

wholly-owned subsidiary of the Issuer that guarantees the Issuer's obligations under its senior secured credit facilities. The notes

will be issued as part of the same series as the $800.0 million of 7.250% senior notes due 2032 originally issued in April 2024.

Surgery Partners intends to use the net proceeds from this offering

for general corporate purposes, including, but not limited to, repaying outstanding borrowings under its revolving credit facility.

This press release shall not constitute an offer to sell or a solicitation

of an offer to buy securities, nor shall there be any offer, solicitation or sale in any jurisdiction in which, or to any person to whom,

such offer, solicitation or sale would be unlawful. The Notes and the Guarantees are being offered and sold only to persons reasonably

believed to be "qualified institutional buyers" in the United States pursuant to Rule 144A under the Securities Act, and to

non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes and the Guarantees have not

been, and will not be, registered under the Securities Act or any state securities laws and may not be offered or sold in the United States

absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.

About Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading

healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions

for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest

and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery

centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.

Forward-Looking Statements

This press release contains forward-looking statements, including those

regarding the expected closing of the Notes offering and Surgery Partners' intention to offer and sell, and apply the net proceeds

of, the Notes. These statements include, but are not limited to, the Company's expectations regarding the proposed offering. These

statements can be identified by the use of words such as "believes," "anticipates," "expects," "intends,"

"plans," "continues," "estimates," "predicts," "projects," "forecasts,"

and similar expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and

are subject to risks, uncertainties and other factors that may cause actual results to differ materially from the expectations discussed

in, or implied by, the forward-looking statements. Many of these factors are beyond our ability to control or predict including, without

limitation, the risk that the proposed offering is not completed on the terms or in the amounts anticipated, or at all, and the other

risks and uncertainties identified and discussed in the Company's reports filed with the SEC, including in Item 1A under the heading

"Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 7, 2025

and the Company's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, filed

on May 12, 2025, August 5, 2025 and November 10, 2025, respectively. Except as required by law, neither the Company nor the Issuer undertakes

any obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report,

or to reflect the occurrence of unanticipated events or circumstances.

Surgery Partners Investor Relations